SeraCare Life Sciences Inc. (Nasdaq: SRLS) announced that it is being acquired by an affiliate of Linden Capital Partners in a deal that is worth approximately $82 million.

• Do you own shares of SeraCare Life Sciences Inc. (Nasdaq: SRLS)?

• Did you buy SRLS shares before February 13, 2012?

• Do you think that the proposed deal is unfair to SRLS shareholders? Is $4 in cash per share too low for SeraCare Life Sciences Inc. (Nasdaq: SRLS)?

If you own any amount of SRLS shares, contact our law firm today to protect your rights.

Our law firm believes that the price offered by this deal may not reflect the full value of SRLS. Our law firm is investigating potential claims against the board of directors of SRLS concerning possible breaches of fiduciary duty and other violations of securities laws related to the agreement to be purchased by an affiliate of Linden Capital Partners in a deal that is worth approximately $82 million. Please contact us for a free consultation if you own any amount of SRLS shares.

Own SRLS stock?

If you are a shareholder of any amount of SRLS complete the form on this page or call Attorney Bill Kyros or George Pressly at 1-800-934-2921 to discuss your rights.

Kyros & Pressly LLP is a Boston-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions.